Concepedia

C. L. Vogel

CL

Statistics

Publications

12

Citations

444

H-Index

11

Active since

1972

Affiliations

Sarah Cannon(Current)

Sylvester Comprehensive Cancer Center

University of Alabama at Birmingham

University of Miami

University of Iowa

C. L. Vogel is an author at Sarah Cannon specializing in medicine, oncology, and breast oncology.

Publications per year

1972–2011

12

Publications

12

Gemcitabine as First-Line Therapy in Patients with Metastatic Breast Cancer: A Phase II Trial

Martin E. Blackstein, C. L. Vogel, Roy M. Ambinder et al. · Oncology · 2002 · 161 citations

, , +17

A phase II study of trastuzumab-DM1 (T-DM1), a HER2 antibody-drug conjugate (ADC), in patients (pts) with HER2+ metastatic breast cancer (MBC): Final results

C. L. Vogel, Howard A. Burris, Steven Limentani et al. · Journal of Clinical Oncology · 2009 · 63 citations

, , +17

Studies on levamisole--induced agranulocytosis

JS Thompson, JM Herbick, LW Klassen et al. · Blood · 1980 · 57 citations

, , +4

Studies on levamisole--induced agranulocytosis

Thompson Js, JM Herbick, LW Klassen et al. · Blood · 1980 · 53 citations · Full text

, , +4

Phase II study of mitomycin C and vinblastine in women with advanced breast cancer refractory to standard cytotoxic therapy.

Denefrio Jm, East Dr, Troner Mb et al. · PubMed · 1978 · 21 citations

, , +15

1–5 of 12